Clostridioides difficile is one of the most common nosocomial gastrointestinal pathogens,
and recurrence is a problematic issue because approximately 20–30% of patients …

Clostridioides difficile is the number one cause of hospital-acquired infections in the United
States and one of the CDC's urgent-level pathogen threats. The inflammation caused by …

Clostridioides difficile (C. difficile) is a gram-positive, anaerobic spore-forming bacterium and
a major cause of antibiotic-associated diarrhea. Humans are naturally resistant to C. difficile …

Clostridioides difficile infection (CDI) is a significant worry within healthcare institutions and
the community. It is one of the leading agents causing severe diarrhea worldwide. Effective …

Spore formation and germination are essential for the bacterial pathogen Clostridioides
difficile to transmit infection. Despite the importance of these developmental processes to the …

Recently, the recommendations for the treatment of Clostridioides difficile infection (CDI)
have been updated. However, in addition to the clinical efficacy data, the drug of choice …

The infection caused by Clostridioides difficile represents one of the bacterial infections with
the greatest increase in incidence among nosocomial infections in recent years. C. difficile is …

Introduction Clostridioides difficile infection (CDI) is a major healthcare problem in the
developed world, and effective management of recurrent infection remains one of the …

Clostridioides difficile is a Gram-positive, spore-forming anaerobic bacterial pathogen that
causes severe gastrointestinal infection in humans. This review provides background …

The pathogenesis of recurrent Clostridium difficile infection (CDI) is still poorly understood.
The risk of recurrence is approximately 20% after an initial CDI episode and dramatically …